AzTrials
AzTrials

Cardiovascular Risk FactorBELINDANCT02899416

Better Life by Nutrition During Adulthood

An observational study of Cardiovascular Risk Factor, run by University Hospital, Lille at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

BELINDA is a follow'up of subjects included 10 years ago in HELENA study which was a cross-sectional study carried out from 2006 to 2007 in more than 3500 adolescents aged from 12.5 to 17.5 years old through 10 Europeans towns from 9 countries. Read more about this study

Who is it for?
Ages 20 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Cardiovascular Risk Factor
How many people
72 participants
Where
1 siteFrance
Study dates
23 Feb 2017to 25 Mar 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: BELINDA is a follow'up of subjects included 10 years ago in HELENA study which was a cross-sectional study carried out from 2006 to 2007 in more than 3500 adolescents aged from 12.5 to 17.5 years old through 10 Europeans towns from 9 countries. BELINDA will retest subjects from Lille and Ghent

Who may be able to join

  • Women of men participating to HELENA study 2006-2007
  • Aged from 20 to 35 years.
  • Signed informed consent

Who cannot join

  • Pregnant or lactating women

Trial locations and contacts

1 site in 1 country.

France1 site

  • CHRU,Hôpital Jeanne de Flandres

    Lille

Other trials in France

About this study

Official title: Better Life by Nutrition During Adulthood : Identification of Factors Present in Adolescence Cardiovascular Risk in Young Adults

BELINDA is a follow'up of subjects included 10 years ago in HELENA study which was a cross-sectional study carried out from 2006 to 2007 in more than 3500 adolescents aged from 12.5 to 17.5 years old through 10 Europeans towns from 9 countries.

BELINDA main objective is to assess CV risk using PDAY score (Pathobiological Determinants of Atherosclerosis in Youth) during young adulthood (20 to 31 years) and analyze lifestyle risk factors from adolescence (12 to 18 years). This analyze may define new CV risk factors and risk population cluster.

Read the detailed description

BELINDA subjects from Lille, Ghent , Zaragoza and Roma will be re-tested using a part of HELENA test battery and some new evaluation criteria.

Keywords
cardiovascular risk, young adulthood

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PDAY score (Pathobiological Determinants of Atherosclerosis in Youth)

    PDAY score is a composite score which will be calculated using adult data including Gender, HDL non cholesterol, HDL cholesterol. Glucose level, Blood pressure, Tobacco consumption and BMI.

    Measured: one day

Secondary outcomes (9)

  1. Diet Quality Index Score

    data collected using HELENA-DIAT, an electronic dietary recall, data in DQI score unit.

    DQI score is ranking from 0 to 9 unit and is based on three basic principles for a healthy diet: quality; diversity; balance. Furthermore, the daily diet was divided into nine recommended food groups, namely (1) water, (2) bread and cereals, (3) grains and potatoes, (4) vegetables, (5) fruit, (6) milk products (7), cheese, (8) meat, fish, eggs and substitutes, and (9) fats and oils.

    Measured: 2 days

  2. Ratio total energy intake

    data collected using HELENA-DIAT, an electronic dietary recall, data in kcal/d, data for recommended total energy intake will be collected using national reference chart.

    Measured: 2 days

  3. ratio of dietary n-6/n-3 polyunsaturated fatty acids (PUFA)

    data collected using HELENA-DIAT, an electronic dietary recall, data in ratio calculated using a food composition data base. PUFA is expressed in mg/day daily intake.

    Measured: 2 days

  4. consumption in dietary salt intake

    data collected using HELENA-DIAT, an electronic dietary recall, data in mg/day daily intake calculated using a food composition data base.

    Measured: 2 days

  5. Physical activity

    data collected using a GT3X accelerometer data in daily counts/min

    Measured: 7 days

  6. Endurance

    data collected using Dr Leger Shuttle run test, data in VO2max ml/kg/min

    Measured: 1 day

  7. Ratio waist-to-hip

    data collected using anthropometric measurements, data in ratio. Data are expressed in centimeter

    Measured: 1 day

  8. Fat mass

    data collected using anthropometric measurements, data in % of fat mass, expressed in kg

    Measured: 1 day

  9. Education level

    data collected using a Socio-economic questionnaire, data in Education level 8 digits

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2016 (estimated)
  2. Study start23 Feb 2017
  3. Primary completion25 Mar 2022
  4. Study completion25 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02899416
Sponsor's protocol ID
2015_24
Other IDs
2016-A00386-45
Acronym
BELINDA
Status last verified
Sep 2022
First submitted
24 Aug 2016
Last updated
23 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Morcel J, Beghin L, Michels N, De Ruyter T, Drumez E, Cailliau E, Polito A, Le Donne C, Barnaba L, Azzini E, De Henauw S, Miguel Berges ML, Cacau LT, Moreno LA, Gottrand F. Nutritional and physical fitness parameters in adolescence impact cardiovascular health in adulthood. Clin Nutr. 2024 Aug;43(8):1857-1864. doi: 10.1016/j.clnu.2024.06.022. Epub 2024 Jun 26.

    PubMed 38959665

  • Beghin L, Morcel J, Michels N, Leroy M, Ternynck C, Labreuche J, De Henauwn S, Miguel-Berges ML, Polito A, Moreno LA, Gottrand F. High nutritional knowledge during adolescence is associated with healthier dietary habits in adulthood: a longitudinal cohort study. Eur J Nutr. 2026 Jun 2;65(4):149. doi: 10.1007/s00394-026-03968-y.

    PubMed 42228155

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiovascular Risk Factor, run by University Hospital, Lille at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PDAY score (Pathobiological Determinants of Atherosclerosis in Youth) (time frame: one day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02899416, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2025; AzTrials last refreshed its copy on 6 Nov 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in